Transmedics Group Inc’s recently made public that its President & CEO Hassanein Waleed H unloaded Company’s shares for reported $1.14 million on Apr 10 ’24. In the deal valued at $95.09 per share,12,000 shares were sold. As a result of this transaction, Hassanein Waleed H now holds 74,087 shares worth roughly $6.8 million.
Then, Khayal Tamer I sold 15,512 shares, generating $1,403,082 in total proceeds. Upon selling the shares at $90.45, the Chief Commercial Officer now owns 25,185 shares.
Before that, Khayal Tamer I sold 4,388 shares. Transmedics Group Inc shares valued at $394,920 were divested by the Chief Commercial Officer at a price of $90.00 per share. As a result of the transaction, Khayal Tamer I now holds 25,185 shares, worth roughly $2.31 million.
Piper Sandler initiated its Transmedics Group Inc [TMDX] rating to an Overweight in a research note published on March 28, 2024; the price target was $95. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in mid July with a ‘”an Outperform”‘ rating. JP Morgan also remained covering TMDX and has increased its forecast on August 02, 2022 with a “an Overweight” recommendation from previously “Neutral” rating. JP Morgan revised its rating on October 08, 2020. It rated TMDX as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of TMDX
On Friday, Transmedics Group Inc [NASDAQ:TMDX] saw its stock fall -2.27% to $91.82. Over the last five days, the stock has gained 7.97%. Transmedics Group Inc shares have risen nearly 16.33% since the year began. Nevertheless, the stocks have risen 31.02% over the past one year. While a 52-week high of $99.63 was reached on 04/10/24, a 52-week low of $36.42 was recorded on 03/25/24. SMA at 50 days reached $83.03, while 200 days put it at $72.33. A total of 0.68 million shares were traded, compared to the trading of 0.67 million shares in the previous session.
Levels Of Support And Resistance For TMDX Stock
The 24-hour chart illustrates a support level at 90.36, which if violated will result in even more drops to 88.89. On the upside, there is a resistance level at 93.68. A further resistance level may holdings at 95.53. The Relative Strength Index (RSI) on the 14-day chart is 64.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 12.25, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 21.02%. Stochastics %K at 85.98% indicates the stock is a selling.
The most recent change occurred on April 07, 2020 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $25 price target.
